Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

156.76
+2.731.77%
Pre-market: 160.143.38+2.16%04:13 EDT
Volume:878.44K
Turnover:137.13M
Market Cap:15.99B
PE:22.98
High:157.03
Open:154.31
Low:153.70
Close:154.03
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:0.81
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.33
PE(LYR):33.57

Loading ...

Nxera partner Neurocrine starts Phase 2 trial of NBI-1117570 in schizophrenia

Reuters
·
Apr 13

Neurocrine Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Apr 10

Neurocrine Is Maintained at Buy by Citigroup

Dow Jones
·
Apr 08

Jefferies Reaffirms Their Buy Rating on Neurocrine (NBIX)

TIPRANKS
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE -Virgin Galactic, Humana, Broadcom

Reuters
·
Apr 07

Neurocrine Biosciences Inc : Wedbush Raises Target Price to $166 From $151

THOMSON REUTERS
·
Apr 07

BUZZ-HC Wainwright lifts PT on Neurocrine after Soleno deal

Reuters
·
Apr 07

Neurocrine Biosciences Inc : H.c. Wainwright Raises Target Price to $215 From $192

THOMSON REUTERS
·
Apr 07

Neurocrine price target raised to $166 from $151 at Baird

TIPRANKS
·
Apr 07

Neurocrine price target raised to $242 from $204 at Citi

TIPRANKS
·
Apr 07

Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull

TIPRANKS
·
Apr 07

Neurocrine Biosciences Inc : Canaccord Genuity Raises Target Price to $200 From $164

THOMSON REUTERS
·
Apr 07

Neurocrine Biosciences Inc : Oppenheimer Raises Target Price to $220 From $192

THOMSON REUTERS
·
Apr 07

Dow Jones Top Company Headlines at 7 PM ET: Broadcom to Supply AI Chips to Google, Computing Capacity to Anthropic in Expanded Collaboration | Amazon ...

Dow Jones
·
Apr 07

Analysts Conflicted on These Healthcare Names: Oncolytics Biotech (ONCY) and Neurocrine (NBIX)

TIPRANKS
·
Apr 07

Dow Jones Top Company Headlines at 5 PM ET: Amazon and U.S. Postal Service Reach Delivery Deal | Gulf ...

Dow Jones
·
Apr 07

Oppenheimer Adjusts Neurocrine Biosciences Price Target to $220 From $192, Maintains Outperform Rating

MT Newswires Live
·
Apr 07

US STOCKS-Wall St clings to gains as investors assess US-Iran negotiations, threats

Reuters
·
Apr 07

Top Midday Gainers

MT Newswires Live
·
Apr 07